Financial reports
10-K
2023 FY
Annual report
22 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
24 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
10-K
2021 FY
Annual report
24 Feb 22
Current reports
8-K
Evolent Announces Fourth Quarter and Full Year 2023 Results
22 Feb 24
8-K
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors
14 Feb 24
8-K
Results of Operations and Financial Condition
8 Jan 24
8-K
Entry into a Material Definitive Agreement
8 Dec 23
8-K
Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan
6 Dec 23
8-K
Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan
5 Dec 23
8-K
Other Events
3 Nov 23
8-K
Combined Financial Statements
2 Nov 23
8-K
Evolent Announces Third Quarter 2023 Results
2 Nov 23
8-K/A
Combined Unaudited Financial Statements
13 Oct 23
Registration and prospectus
S-3ASR
Automatic shelf registration
23 Feb 24
424B7
Prospectus with selling stockholder info
3 Nov 23
424B7
Prospectus with selling stockholder info
3 Nov 23
S-8
Registration of securities for employees
2 Nov 23
D
$727.99 k in equity, sold $727.99 k, 18 investors
26 May 23
D
$182M in equity, sold $125M, 6 investors
11 Aug 22
424B7
Prospectus with selling stockholder info
3 Aug 22
S-3ASR
Automatic shelf registration
3 Aug 22
D
$450K in equity, sold $450K, 18 investors
30 Nov 21
D
$65M in equity, sold $42.5M, 15 investors
15 Oct 21
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
21 May 21
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
30 Apr 21
PRE 14A
Preliminary proxy
20 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
Other
UPLOAD
Letter from SEC
12 Jul 23
CORRESP
Correspondence with SEC
5 Jul 23
UPLOAD
Letter from SEC
5 Jun 23
UPLOAD
Letter from SEC
24 May 17
CORRESP
Correspondence with SEC
23 May 17
UPLOAD
Letter from SEC
17 May 17
UPLOAD
Letter from SEC
9 Nov 16
CORRESP
Correspondence with SEC
13 Oct 16
UPLOAD
Letter from SEC
29 Sep 16
EFFECT
Notice of effectiveness
12 Aug 16
Ownership
SC 13G/A
JPMORGAN CHASE & CO
9 Apr 24
4
Russell Monroe Glass
5 Mar 24
4
Aammaad Shams
5 Mar 24
4
Emily Ann Rafferty
5 Mar 24
4
Jonathan Weinberg
5 Mar 24
4
John Paul Johnson
5 Mar 24
4
Seth Blackley
5 Mar 24
4
Daniel Joseph McCarthy
5 Mar 24
3
Russell Monroe Glass
26 Feb 24
4
Seth Blackley
26 Feb 24